These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27462870)

  • 1. Current approach to the management of psoriatic arthritis according to a sample of Italian rheumatologists.
    Marchesoni A; Lubrano E; Manara M; Ramonda R; Salvarani C; Olivieri I
    Clin Exp Rheumatol; 2016; 34(6):1051-1058. PubMed ID: 27462870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA).
    Lapadula G; Marchesoni A; Salaffi F; Ramonda R; Salvarani C; Punzi L; Costa L; Caso F; Simone D; Baiocchi G; Scioscia C; Di Carlo M; Scarpa R; Ferraccioli G
    Reumatismo; 2016 Dec; 68(3):126-136. PubMed ID: 27981814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology.
    Gladman DD; Chandran V; Thavaneswaran A; Zummer M
    J Rheumatol; 2012 Sep; 39(9):1850-3. PubMed ID: 22859361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national survey on the management of psoriatic arthritis using the Delphi method.
    Lubrano E; Cantini F; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Marchesoni A
    Clin Exp Rheumatol; 2017; 35(2):214-220. PubMed ID: 27607572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis.
    Lahiri M; Teng GG; Cheung PP; Suresh E; Chia FL; Lui NL; Koh DR; Koh WH; Leong KP; Lim AYN; Ng SC; Thumboo J; Lau TC; Leong KH
    Int J Rheum Dis; 2017 Oct; 20(10):1527-1540. PubMed ID: 26353916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis.
    Salvarani C; Olivieri I; Pipitone N; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M;
    Clin Exp Rheumatol; 2006; 24(1):70-8. PubMed ID: 16539822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology.
    Salvarani C; Pipitone N; Marchesoni A; Cantini F; Cauli A; Lubrano E; Punzi L; Scarpa R; Spadaro A; Matucci-Cerinic M; Olivieri I;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S28-41. PubMed ID: 21906425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology.
    Marchesoni A; Olivieri I; Salvarani C; Pipitone N; D'Angelo S; Mathieu A; Cauli A; Punzi L; Ramonda R; Scarpa R; Maccarone M; Lubrano E
    Clin Exp Rheumatol; 2017; 35(6):991-1010. PubMed ID: 29185959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study.
    Mease PJ; Liu C; Siegel E; Richmond H; Wu M; Chen L; Douglas K; Lockshin B
    Am J Clin Dermatol; 2019 Dec; 20(6):873-880. PubMed ID: 31612380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms.
    Taylor SL; Petrie M; O'Rourke KS; Feldman SR
    J Dermatolog Treat; 2009; 20(6):350-3. PubMed ID: 19878036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature.
    Gratacos-Masmitja J; Luelmo-Aguilar J; Zarco-Montejo P; Botella-Estrada R; Carrizosa-Esquivel AM; Garcia-Vivar ML; Perez-Barrio S; Roman-Ivorra JA; Ruiz-Montesino MD; Lopez-Estebaranz JL
    Adv Ther; 2017 Jan; 33(12):2150-2159. PubMed ID: 27757814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
    Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
    Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus on the management of patients with psoriatic arthritis in a dermatology setting.
    Gisondi P; Altomare G; Ayala F; Conti A; Dapavo P; De Simone C; Foti C; Idolazzi L; Lubrano E; Malara G; Marchesoni A; Olivieri I; Parodi A; Peris K; Piaserico S; Salvarani C; Scarpa R; Girolomoni G
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):515-528. PubMed ID: 29220551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.
    Torre Alonso JC; Díaz Del Campo Fontecha P; Almodóvar R; Cañete JD; Montilla Morales C; Moreno M; Plasencia-Rodríguez C; Ramírez García J; Queiro R
    Reumatol Clin (Engl Ed); 2018; 14(5):254-268. PubMed ID: 29111261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Rheumatologists' Perspectives on Moderate Psoriatic Arthritis and Oligoarticular Psoriatic Arthritis.
    Gladman DD; Starr M; Cividino A; Gaudreau AJ; Jelley J; Nicholson D; Karsh J
    J Rheumatol; 2021 Nov; 48(11):1692-1697. PubMed ID: 33993114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of psoriatic arthritis switch quality assessment tool (PASQAL) - an outcomes measurement tool to assess the quality of biologic switch decisions in psoriatic arthritis.
    Laires PA; Carrilho M; Tavares-Costa J; Lucas P; Machado P; Cunha-Miranda L; Pimentel-Santos F; Santos H; Vieira-Sousa E; Santos MJ
    Acta Reumatol Port; 2020; 45(1):46-57. PubMed ID: 32578579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis].
    Fernández Sueiro JL; Juanola Roura X; Cañete Crespillo Jde D; Torre Alonso JC; García de Vicuña R; Queiro Silva R; Ariza Ariza R; Batlle Gualda E; Loza Santamaría E;
    Reumatol Clin; 2011; 7(3):179-88. PubMed ID: 21794810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA.
    Baum EW; Schwartzman S
    Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.